TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vaccinkliniken Sverige AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,327
|
7,748
|
11,585 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
660
|
1,953
|
5,255 |
EBITDA |
680
|
1,977
|
5,284 |
Total assets |
2,021
|
2,335
|
1,839 |
Current assets |
2,006
|
2,304
|
1,784 |
Current liabilities |
642
|
1,162
|
1,478 |
Equity capital |
1,379
|
1,174
|
360 |
- share capital |
51
|
47
|
49 |
Employees (average) |
5
|
7
|
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.2%
|
50.3%
|
19.6% |
Turnover per employee |
1,265
|
1,107
|
1,158 |
Profit as a percentage of turnover |
10.4%
|
25.2%
|
45.4% |
Return on assets (ROA) |
32.7%
|
83.7%
|
285.8% |
Current ratio |
312.5%
|
198.3%
|
120.7% |
Return on equity (ROE) |
47.9%
|
166.4%
|
1459.7% |
Change turnover |
-1,970
|
-3,489
|
6,501 |
Change turnover % |
-24%
|
-31%
|
128% |
Chg. No. of employees |
-2
|
-3
|
7 |
Chg. No. of employees % |
-29%
|
-30%
|
233% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.